<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Environ Health Perspect</journal-id><journal-title>Environmental Health Perspectives</journal-title><issn pub-type="ppub">0091-6765</issn><publisher><publisher-name>National Institute of Environmental Health Sciences</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1289/ehp.10318</article-id><article-id pub-id-type="publisher-id">ehp0115-001617</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Particulate Air Pollution, Oxidative Stress Genes, and Heart Rate Variability in an Elderly Cohort</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Chahine</surname><given-names>Teresa</given-names></name><xref ref-type="aff" rid="af1-ehp0115-001617">1</xref></contrib><contrib contrib-type="author"><name><surname>Baccarelli</surname><given-names>Andrea</given-names></name><xref ref-type="aff" rid="af1-ehp0115-001617">1</xref><xref ref-type="aff" rid="af2-ehp0115-001617">2</xref></contrib><contrib contrib-type="author"><name><surname>Litonjua</surname><given-names>Augusto</given-names></name><xref ref-type="aff" rid="af3-ehp0115-001617">3</xref></contrib><contrib contrib-type="author"><name><surname>Wright</surname><given-names>Robert O.</given-names></name><xref ref-type="aff" rid="af1-ehp0115-001617">1</xref><xref ref-type="aff" rid="af3-ehp0115-001617">3</xref></contrib><contrib contrib-type="author"><name><surname>Suh</surname><given-names>Helen</given-names></name><xref ref-type="aff" rid="af1-ehp0115-001617">1</xref></contrib><contrib contrib-type="author"><name><surname>Gold</surname><given-names>Diane R.</given-names></name><xref ref-type="aff" rid="af1-ehp0115-001617">1</xref><xref ref-type="aff" rid="af3-ehp0115-001617">3</xref></contrib><contrib contrib-type="author"><name><surname>Sparrow</surname><given-names>David</given-names></name><xref ref-type="aff" rid="af4-ehp0115-001617">4</xref></contrib><contrib contrib-type="author"><name><surname>Vokonas</surname><given-names>Pantel</given-names></name><xref ref-type="aff" rid="af4-ehp0115-001617">4</xref></contrib><contrib contrib-type="author"><name><surname>Schwartz</surname><given-names>Joel</given-names></name><xref ref-type="aff" rid="af1-ehp0115-001617">1</xref><xref ref-type="corresp" rid="c1-ehp0115-001617"/></contrib></contrib-group><aff id="af1-ehp0115-001617"><label>1</label> Department of Environmental Health, Harvard School of Public Health, Boston, Massachusetts, USA</aff><aff id="af2-ehp0115-001617"><label>2</label> Center of Molecular Epidemiology and Genetics; and EPOCA Epidemiology Research Center, University of Milan and IRCCS Maggiore Hospital, Mangiagalli and Regina Elena Foundation, Milan, Italy</aff><aff id="af3-ehp0115-001617"><label>3</label> Channing Laboratory, Department of Medicine, Brigham and Women&#x02019;s Hospital, Harvard Medical School, Boston, Massachusetts, USA</aff><aff id="af4-ehp0115-001617"><label>4</label> VA Normative Aging Study, Veterans Affairs Boston Healthcare System and the Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA</aff><author-notes><corresp id="c1-ehp0115-001617">Address correspondence to J. Schwartz, Exposure, Epidemiology, and Risk Program, Harvard School of Public Health, 401 Park Dr., Suite 415 W, PO Box 15698, Boston, MA 02215 USA. Telephone: (617) 384-8752. Fax: (617) 384-8745. E-mail: <email>jschwrtz@hsph.harvard.edu</email></corresp><fn><p>The authors declare they have no competing financial interests.</p></fn></author-notes><pub-date pub-type="ppub"><month>11</month><year>2007</year></pub-date><pub-date pub-type="epub"><day>20</day><month>8</month><year>2007</year></pub-date><volume>115</volume><issue>11</issue><fpage>1617</fpage><lpage>1622</lpage><history><date date-type="received"><day>30</day><month>3</month><year>2007</year></date><date date-type="accepted"><day>11</day><month>8</month><year>2007</year></date></history><copyright-statement>This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original DOI.</copyright-statement><copyright-year>2007</copyright-year><abstract><sec><title>Background and objectives</title><p>We have previously shown that reduced defenses against oxidative stress due to glutathione <italic>S</italic>-transferase M1 (<italic>GSTM1</italic>) deletion modify the effects of PM<sub>2.5</sub> (fine-particulate air pollution of &#x0003c; 2.5 &#x003bc;m in aerodynamic diameter) on heart rate variability (HRV) in a cross-sectional analysis of the Normative Aging Study, an elderly cohort. We have extended this to include a longitudinal analysis with more subjects and examination of the GT short tandem repeat polymorphism in the heme oxygenase-1 (<italic>HMOX-1</italic>) promoter.</p></sec><sec sec-type="methods"><title>Methods</title><p>HRV measurements were taken on 539 subjects. Linear mixed effects models were fit for the logarithm of HRV metrics&#x02014;including standard deviation of normal-to-normal intervals (SDNN), high frequency (HF), and low frequency (LF)&#x02014;and PM<sub>2.5</sub> concentrations in the 48 hr preceding HRV measurement, controlling for confounders and a random subject effect.</p></sec><sec><title>Results</title><p>PM<sub>2.5</sub> was significantly associated with SDNN (<italic>p</italic> = 0.04) and HF (<italic>p</italic> = 0.03) in all subjects. There was no association in subjects with <italic>GSTM1</italic>, whereas there was a significant association with SDNN, HF, and LF in subjects with the deletion. Similarly, there was no association with any HRV measure in subjects with the short repeat variant of <italic>HMOX</italic>-1, and significant associations in subjects with any long repeat. We found a significant three-way interaction of PM<sub>2.5</sub> with <italic>GSTM1</italic> and <italic>HMOX-1</italic> determining SDNN (<italic>p</italic> = 0.008), HF (<italic>p</italic> = 0.01) and LF (<italic>p</italic> = 0.04). In subjects with the <italic>GSTM1</italic> deletion and the <italic>HMOX-1</italic> long repeat, SDNN decreased by 13% [95% confidence interval (CI), &#x02212;21% to &#x02212;4%], HF decreased by 28% (95% CI, &#x02212;43% to &#x02212;9%), and LF decreased by 20% (95% CI, &#x02212;35% to &#x02212;3%) per 10 &#x003bc;g/m<sup>3</sup> increase in PM.</p></sec><sec><title>Conclusions</title><p>Oxidative stress is an important pathway for the autonomic effects of particles.</p></sec></abstract><kwd-group><kwd>air particles</kwd><kwd>air pollution</kwd><kwd>cardiovascular health</kwd><kwd>genetic variation</kwd><kwd><italic>GST</italic></kwd><kwd>heart rate variability</kwd><kwd><italic>HMOX-1</italic></kwd><kwd>PM<sub>2.5</sub></kwd></kwd-group></article-meta></front><body><p>Particulate air pollution (PM) is associated with increased risk of hospitalization and death from cardiovascular disease (<xref ref-type="bibr" rid="b5-ehp0115-001617">Brook et al. 2004</xref>; <xref ref-type="bibr" rid="b12-ehp0115-001617">Forastiere et al. 2005</xref>; <xref ref-type="bibr" rid="b36-ehp0115-001617">Samet et al. 2000</xref>; <xref ref-type="bibr" rid="b38-ehp0115-001617">Schwartz 1999</xref>; <xref ref-type="bibr" rid="b48-ehp0115-001617">Zanobetti and Schwartz 2005</xref>), but the mechanisms underlying such effects are not fully understood. Reductions in heart rate variability (HRV), a noninvasive measure that independently predicts cardiovascular mortality (<xref ref-type="bibr" rid="b44-ehp0115-001617">Tsuji et al. 1996</xref>), have been related to PM exposure, particularly to fine-particulate air pollution of &#x0003c; 2.5 &#x003bc;m in aerodynamic diameter (PM<sub>2.5</sub>) (<xref ref-type="bibr" rid="b7-ehp0115-001617">Creason et al. 2001</xref>; <xref ref-type="bibr" rid="b9-ehp0115-001617">Devlin et al. 2003</xref>; <xref ref-type="bibr" rid="b14-ehp0115-001617">Gold et al. 2000</xref>; <xref ref-type="bibr" rid="b18-ehp0115-001617">Holguin et al. 2003</xref>; <xref ref-type="bibr" rid="b23-ehp0115-001617">Liao et al. 2005a</xref>; <xref ref-type="bibr" rid="b25-ehp0115-001617">Magari et al. 2002</xref>; <xref ref-type="bibr" rid="b30-ehp0115-001617">Park et al. 2005</xref>; <xref ref-type="bibr" rid="b33-ehp0115-001617">Pope et al. 2004</xref>; <xref ref-type="bibr" rid="b39-ehp0115-001617">Schwartz et al. 2005a</xref>).</p><p>Animal experiments indicate that reactive oxygen species (ROS), which have established relevance in the pathogenesis of cardiovascular disease (<xref ref-type="bibr" rid="b10-ehp0115-001617">Dhalla et al. 2000</xref>), are potential mediators for particle effects on HRV and other cardiovascular end points (<xref ref-type="bibr" rid="b5-ehp0115-001617">Brook et al. 2004</xref>; <xref ref-type="bibr" rid="b15-ehp0115-001617">Gurgueira et al. 2002</xref>; <xref ref-type="bibr" rid="b29-ehp0115-001617">Nel 2005</xref>; <xref ref-type="bibr" rid="b34-ehp0115-001617">Rhoden et al. 2004</xref>). While animal models can identify potential mechanisms of particle effects, the relative importance of these pathways in humans at lower doses is not clear and may be determined by examining subjects with genetically determined differences in oxidative-stress defenses. In elderly subjects living in the Boston, Massachusetts, metropolitan area, we recently showed that PM<sub>2.5</sub> levels during the 48 hr before the study were associated with decreased HRV in individuals with the glutathione <italic>S</italic>-transferase M1 (<italic>GSTM1</italic>) deletion, but had no effect in subjects with <italic>GSTM1</italic> present (<xref ref-type="bibr" rid="b40-ehp0115-001617">Schwartz et al. 2005b</xref>).</p><p>Studies showing the effect of just one polymorphism are unlikely to correctly represent the complex etiology of common diseases, and failure to account for gene&#x02013;gene interactions in the search for susceptibility genes has been widely suggested to explain the persisting difficulties in replicating significant findings (<xref ref-type="bibr" rid="b26-ehp0115-001617">Millstein et al. 2006</xref>). Particle exposure induces both heme oxygenase-1 (<italic>HMOX-1)</italic> and <italic>GSTM1</italic> expression through activation of the genetic antioxidant response element (ARE) (<xref ref-type="bibr" rid="b21-ehp0115-001617">Li et al. 2004</xref>). A high number of microsatellite (GT)n dinucleotide repeats in 5&#x02032;-flanking region may reduce <italic>HMOX-1</italic> inducibility by ROS and has been associated with increased risk of coronary artery disease in high-risk groups with hyperlipidemia, diabetes, or current smoking (<xref ref-type="bibr" rid="b6-ehp0115-001617">Chen et al. 2002</xref>; <xref ref-type="bibr" rid="b20-ehp0115-001617">Kaneda et al. 2002</xref>). Consequently, individuals with a high number of (GT)n repeats may be more susceptible to the effects of airborne particles.</p><p>We hypothesized that the gene encoding HMOX-1, which is involved in various aspects of responses against oxidative stress, may <italic>a</italic>) directly modify the effect of ambient PM on HRV and <italic>b</italic>) interact with <italic>GSTM1</italic> to determine which subjects are susceptible to airborne particle effects. To establish the role of the antioxidant response pathway in determining the cardiovascular effects of airborne particles, we examined in the present study the association of PM<sub>2.5</sub> with HRV in a repeated measure study of elderly subjects from the Boston metropolitan area, and evaluated how that association was affected by genetic variation in the <italic>HMOX-1</italic> and <italic>GSTM1</italic> loci.</p><sec sec-type="materials|methods"><title>Materials and Methods</title><sec sec-type="methods"><title>Study population</title><p>Our study population consisted of 539 white males from the Normative Aging Study (NAS), a longitudinal study of aging established in 1963 by the U.S. Veterans Administration (<xref ref-type="bibr" rid="b3-ehp0115-001617">Bell et al. 1972</xref>). Between January 2000 and June 2005, all participants still presenting for examination (<italic>n</italic> = 676) were evaluated for HRV. Of these, 137 subjects were excluded because of heart arrhythmias, measurement time &#x0003c; 3.5 min, or missing potential confounding variables or <italic>HMOX-1</italic> data. Among the remaining 539 subjects, <italic>GSTM1</italic> data were available for 476 subjects, who had one (<italic>n</italic> = 314) or two (<italic>n</italic> = 162) HRV measurements. In subjects with multiple HRV measurements, the time interval between measurements was approximately 3 years. This study was conducted in compliance with all applicable requirements of the U.S. and international regulations (including institutional review board approval). All subjects gave written informed consent prior to the study.</p></sec><sec><title>HRV measurement</title><p>HRV was measured at rest during normal breathing for 7 min using a two-channel (five-lead) ECG monitor (Trillium 3000; Forest Medical, East Syracuse, NY) while the subject was seated. Standard deviation of normal-to-normal intervals (SDNN), high frequency (HF) (0.15&#x02013;0.4 Hz), and low frequency (LF) (0.04 &#x02013;0.15 Hz) were computed with a fast Fourier transform using software (Trillium 3000 PC Companion Software; Forest Medical) complying with established guidelines (<xref ref-type="bibr" rid="b42-ehp0115-001617">Task Force of the European Society of Cardiology and the North American Society of Pacing and Electro-physiology 1996</xref>). In the analysis, we used the 4 consecutive minutes of ECG reading that included the lowest number of artifacts.</p></sec><sec sec-type="methods"><title>Air pollution and weather data</title><p>Continuous PM<sub>2.5</sub> was measured at a stationary monitoring site on the roof of Countway Library of Harvard University in downtown Boston using a Tapered Element Oscillating Microbalance (TEOM; Model 1400A, Rupprecht &#x00026; Patashnick Co., East Greenbush, NY). Meteorologic data was obtained from the Boston airport weather station. The 48-hr moving average of PM<sub>2.5</sub> before each HRV measurement was used as the exposure index, as this exposure period has shown the strongest association in previous studies (<xref ref-type="bibr" rid="b30-ehp0115-001617">Park et al. 2005</xref>).</p></sec><sec><title>HMOX-1 <italic>and</italic> GSTM1 <italic>genotyping.</italic></title><p>The <italic>GSTM1</italic> locus (UniGene Hs.301961; <xref ref-type="bibr" rid="b45-ehp0115-001617">UniGene 2007a</xref>) was amplified at exons 4 and 5 by polymerase chain reaction (PCR) as previously described to differentiate between the null polymorphism and the presence of one or more copies of the gene (<xref ref-type="bibr" rid="b40-ehp0115-001617">Schwartz et al. 2005b</xref>). The <italic>HMOX-1</italic> (UniGene Hs.517581; <xref ref-type="bibr" rid="b46-ehp0115-001617">UniGene 2007b</xref>) microsatellite (GT)n length assay was designed per Yamada and coworkers (<xref ref-type="bibr" rid="b47-ehp0115-001617">Yamada et al. 2000</xref>). Briefly, the <italic>HMOX-1</italic> locus was amplified by PCR at the 5&#x02032; promoter flanking region containing (GT)n repeats with primers as described by Yamada, and the sizes of the PCR products were analyzed with a laser-based automated DNA sequencer (AB 3100; Applied Biosystems, Foster City, CA). Although the exact cutoff for <italic>HMOX-1</italic> modulation is still unknown, constructs with lengths of &#x0003e; 25 repeats showed reduced <italic>HMOX-1</italic> basal promoter activity and decreased transcriptional upregulation in response to various stimuli like H<sub>2</sub>O<sub>2</sub> compared with lengths &#x0003c; 25 repeats (<xref ref-type="bibr" rid="b6-ehp0115-001617">Chen et al. 2002</xref>; <xref ref-type="bibr" rid="b47-ehp0115-001617">Yamada et al. 2000</xref>). In the analysis of the data, we used the 25-repeat cutoff to categorize the study subjects in two categories [&#x0003c; 25 (GT)n repeats in both alleles or &#x02265; 25 (GT)n repeats in at least one allele] based on the <italic>HMOX-1</italic> microsatellite length.</p></sec><sec sec-type="methods"><title>Statistical analysis</title><p>HRV measurements were log<sub>10</sub>-transformed to improve normality. The following potential confounders were chosen <italic>a priori</italic> and included in the analysis: age, body mass index (BMI), mean arterial pressure, fasting blood glucose, cigarette smoking (never/former/current), alcohol consumption (&#x02265; 2 drinks a day, yes/no), use of beta-blockers, calcium channel blockers, acetylcholinesterase (ACE) inhibitors, room temperature, season, and 48-hr moving average of outdoor apparent temperature. Potential nonlinearity between apparent temperature and HRV was accounted for using a linear and quadratic term.</p><p>Because our data included repeated measures of HRV for many participants, our data may lack independence. To deal with this, we fit a mixed effects model (PROC MIXED in SAS version 9.0; SAS Institute Inc., Cary, NC). We assumed:</p><disp-formula><graphic xlink:href="ehp0115-001617e1.jpg" position="float"/></disp-formula><p>where <italic>Y</italic><italic><sub>it</sub></italic> is the logarithm of HRV in subject <italic>i</italic> at time <italic>t</italic>, <italic>b</italic><sub>0</sub> is the overall intercept, and <italic>u</italic><italic><sub>i</sub></italic> is the separate random intercept for subject <italic>i.</italic> In the above, <italic>X</italic><sub>1</sub><italic>&#x02014;X</italic><italic><sub>p</sub></italic> are the covariates measured at each of the visits in which the HRV measurements were taken. This captures the correlation among measurements within the same subject.</p></sec></sec><sec sec-type="results"><title>Results</title><p><xref ref-type="table" rid="t1-ehp0115-001617">Table 1</xref> shows the levels and distribution of the variables used in this study, overall, and for the different combinations of <italic>GSTM1</italic> genotype and <italic>HMOX 1</italic> microsatellite repeat length. The study participants were all male, with average age of 72.8 years (SD = 6.6 years) at the first HRV measurement. No differences among the subpopulations defined by the combinations of <italic>GSTM1</italic> genotype [wild-type or null] and <italic>HMOX-1</italic> microsatellite repeat length [&#x0003c; 25 (GT)n repeats in both alleles or &#x02265; 25 (GT)n repeats in at least one allele] were found in age, BMI, systolic blood pressure, diastolic blood pressure, mean arterial pressure, heart rate, fasting blood glucose, total cholesterol, high-density lipoproteins (HDL), triglyceride, smoking status, alcohol intake (&#x02265; 2 drinks/day), history of coronary heart disease (CHD), diabetes, hypertension, or stroke, and use of beta-blockers, calcium channel blockers, or ACE inhibitors (<xref ref-type="table" rid="t1-ehp0115-001617">Table 1</xref>). The two genes were not associated with each other (<italic>p</italic> &#x0003e; 0.67).</p><p><xref ref-type="table" rid="t2-ehp0115-001617">Table 2</xref> shows the results of the analyses for the association of PM<sub>2.5</sub> with changes inHRV for the entire population (model 1), by <italic>GSTM1</italic> genotype (model 2), and by <italic>HMOX-1</italic> microsatellite (GT)n repeat length (model 3).</p><p>For the entire population, we found that a 10 &#x003bc;g/m<sup>3</sup> increase in ambient PM<sub>2.5</sub> in the 48 hr before the HRV measurement was associated with a 6.8% decrease in SDNN [95% confidence interval (CI), &#x02212;12.9 to &#x02212;0.2; <italic>p</italic> = 0.043] and with a 17.3% decrease in HF (95% CI, &#x02212;30.0 to &#x02212;2.3; <italic>p</italic> = 0.026). Ambient PM<sub>2.5</sub> concentrations were also negatively associated with LF (estimated change = &#x02212;11.2%, 95% CI, &#x02212;22.8 to 2.2), but the result was not statistically significant (<italic>p</italic> = 0.10).</p><p>The PM<sub>2.5</sub>&#x02013;HRV association was modified by <italic>GSTM1</italic> genotype, with PM<sub>2.5</sub> concentrations negatively associated with SDNN, HF, and LF in <italic>GSTM1</italic>-null subjects, whereas no association between PM<sub>2.5</sub> and HRV was found in <italic>GSTM1</italic>&#x02013;wild-type carriers. In subjects with the <italic>GSTM1</italic>-null deletion, a 10-&#x003bc;g/m<sup>3</sup> increase in PM<sub>2.5</sub> was associated with a 10.5% decrease in SDNN (95% CI, &#x02212;18.2 to &#x02212;2.2; <italic>p</italic> = 0.015), a 24.2% decrease in HF (95% CI, &#x02212;39.2 to &#x02212;5.5; <italic>p</italic> = 0.014), and a 17.0% decrease in LF (95% CI, &#x02212;31.0 to &#x02212;0.2; <italic>p</italic> = 0.048). In <italic>GSTM1</italic>&#x02013;wild-type subjects, the estimated decreases in HRV for a 10-&#x003bc;g/m<sup>3</sup> increase in PM<sub>2.5</sub> were 2.0% (95% CI, &#x02212;11.3 to 8.3; <italic>p</italic> = 0.69) for SDNN, 4.0% (95% CI, &#x02212;24.8 to 22.6; <italic>p</italic> = 0.74) for HF, and 0.6% (95% CI, &#x02212;19.0 to 22.0; <italic>p</italic> = 0.95) for LF. However, the <italic>p</italic>-values for statistical interactions between PM<sub>2.5</sub> and <italic>GSTM1</italic> genotype were not significant.</p><p>Similarly, we found that that PM<sub>2.5</sub>&#x02013;HRV association was modified by <italic>HMOX-1</italic> genotypes. Ambient PM<sub>2.5</sub> concentrations were negatively associated with all three HRV outcomes in carriers of at least one allele with &#x02265; 25 microsatellite (GT)n repeats in the <italic>HMOX-1</italic> promoter region, whereas no association between PM<sub>2.5</sub> and HRV was present in carriers of &#x0003c; 25 repeats in both alleles. In subjects with at least one allele with &#x02265; 25 microsatellite (GT)n repeats, a 10-&#x003bc;g/m<sup>3</sup> increase in PM<sub>2.5</sub> was associated with a 8.5% decrease in SDNN (95% CI, &#x02212;14.8 to &#x02212;1.8; <italic>p</italic> = 0.014), a 20.1% decrease in HF (95% CI, &#x02212;32.9 to &#x02212;5.0; <italic>p</italic> = 0.012), and a 14.0% decrease in LF (95% CI, &#x02212;25.7 to &#x02212;0.5; <italic>p</italic> = 0.043). The <italic>p</italic>-value for statistical interactions between PM<sub>2.5</sub> and <italic>GSTM1</italic> genotype was marginally significant (<italic>p</italic> = 0.059) when the SDNN component of HRV was considered but was not significant for HF (<italic>p</italic> = 0.14) and LF (<italic>p</italic> = 0.11).</p><p>We further evaluated the interrelationship between PM<sub>2.5,</sub><italic>GSTM1</italic>, and <italic>HMOX-1</italic> by estimating the effect of PM<sub>2.5</sub> on HRV within each combination of the <italic>GSTM1</italic> genotypes and <italic>HMOX-1</italic> microsatellite repeat length categories (<xref ref-type="table" rid="t3-ehp0115-001617">Table 3</xref>). These results indicate a clear trend of increasingly negative coefficients as we move across gene categories. In carriers of both the <italic>GSTM1</italic>-null deletion and at least one allele with &#x02265; 25 <italic>HMOX-1</italic> microsatellite (GT)n repeats, PM<sub>2.5</sub> was negatively associated with all three HRV outcomes, whereas no significant association was found in subjects with any other combinations. In subjects carrying the <italic>GSTM1</italic>-null deletion and at least one allele with &#x02265; 25 <italic>HMOX-1</italic> microsatellite (GT)n repeats, a 10-&#x003bc;g/m<sup>3</sup> increase in PM<sub>2.5</sub> in the 48 hr before the HRV measurement was associated with a &#x02212;12.7% decrease in SDNN (95% CI, &#x02212;20.6 to &#x02212;3.9; <italic>p</italic> = 0.0059), a 27.8% decrease in HF (95% CI, &#x02212;43.0 to &#x02212;8.5; <italic>p</italic> = 0.0073), and a 20.1% decrease in LF (95% CI, &#x02212;34.5 to &#x02212;2.7; <italic>p</italic> = 0.0261). <italic>GSTM1</italic> genotypes and <italic>HMOX-1</italic> microsatellite repeat lengths had a combined effect on the association between PM<sub>2.5</sub> and HRV, as shown in <xref ref-type="table" rid="t3-ehp0115-001617">Table 3</xref> by the significant three-way interaction term between <italic>GSTM1</italic>, <italic>HMOX-1</italic>, and PM<sub>2.5</sub> (coded as PM<sub>2.5</sub> &#x000d7; a trend variable that is 1 for <italic>GSTM1</italic> present and both short repeats, 2 for <italic>GSTM1</italic> null and both short repeats, 2 for one long repeat and <italic>GSTM1</italic> present, and 4 for <italic>GSTM1</italic> null and at least one long repeat).</p><p>To test whether the effect modification by genotype was driven by a few individuals or represented a more general shifting of the distribution of PM<sub>2.5</sub>&#x02013;HRV slopes, we refit our mixed models, dropping the interaction terms with genotype but allowing for random subject-specific slopes. <xref ref-type="fig" rid="f1-ehp0115-001617">Figure 1</xref> shows the distribution of subject-specific PM<sub>2.5</sub> slopes for SDNN by three categories of genotype (<italic>HMOX-1</italic> &#x0003c; 25 repeats and <italic>GSTM1</italic> wt, either <italic>HMOX-1</italic> &#x02265; 25 repeats or <italic>GSTM1</italic> null, or both <italic>HMOX-1</italic> &#x02265; 25 repeats and <italic>GSTM1</italic> null). The shift to the left of the distributions does not appear to be driven by outliers. The same shift in the distributions was observed also for the HF and LF components (data not shown).</p><p>Goodness of fit of the three-way interaction models was evaluated using the Akaike Information Criterion (AIC). AICs for models including the three-way interaction term were lower than those obtained from corresponding models including the main effects of GSTM1, HMOX-1, and PM<sub>2.5,</sub> as well as the two-way interactions between <italic>GSTM1</italic> and PM<sub>2.5</sub> and <italic>HMOX-1</italic> and PM<sub>2.5,</sub> thus indicating better goodness of fit.</p></sec><sec sec-type="discussion"><title>Discussion</title><p>Our study, based on an elderly population in Boston, showed that functional genetic variations in <italic>GSTM1</italic> and <italic>HMOX-1</italic>, both of which are related to defenses against oxidative stress, modify the effects of PM<sub>2.5</sub> on HRV. In the present work, we have extended our previous results examining the modification of the PM<sub>2.5</sub>&#x02013;HRV association by <italic>GSTM1</italic> (<xref ref-type="bibr" rid="b40-ehp0115-001617">Schwartz et al. 2005b</xref>) to include other HRV outcomes and repeated measures on subjects, to show effect modification by <italic>HMOX-1</italic>, and to show a three-way interaction between the two genes and combustion particles.</p><p>This work is part of a series of studies seeking to examine the potential pathways by which particles affect HRV. Specifically, we are looking at oxidative stress and endothelial function as potential pathways to this outcome. We hypothesize that if a pathway is important in the effect of PM<sub>2.5</sub> on HRV, then factors that modify that pathway, either genes or drugs, may modify the PM<sub>2.5</sub> response. We are also looking at metal-processing pathways as an indirect test of the hypothesis that metals on the PM<sub>2.5</sub> particles play an important role in the HRV response (<xref ref-type="bibr" rid="b31-ehp0115-001617">Park et al. 2006</xref>).</p><p>In our previous work on the same population we showed that ambient PM<sub>2.5</sub> concentrations averaged over the 48 hr before the examination were associated with a reduction HF, with negative, albeit nonsignificant, associations were seen with SDNN and LF (<xref ref-type="bibr" rid="b30-ehp0115-001617">Park et al. 2005</xref>). In the present work, based on longer follow-up and additional HRV measurements, we were also able to show a significant effect on SDNN, as well as a more pronounced, although still nonsignificant, negative association with LF.</p><p>As part of our examination of oxidative stress we have previously shown that particles had no effect on HRV in subjects with the functional <italic>GSTM1</italic> polymorphism (<italic>GSTM1</italic>&#x02013;wild-type) but had a substantially increased effect in those with the deletion (<italic>GSTM1</italic>-null) (<xref ref-type="bibr" rid="b40-ehp0115-001617">Schwartz et al. 2005b</xref>). Similarly, we showed that statin use and obesity, which both modify ROS production, altered PM<sub>2.5</sub> effects on HRV (<xref ref-type="bibr" rid="b40-ehp0115-001617">Schwartz et al. 2005b</xref>), thus confirming the critical role of oxidative stress pathways. In this article, we extend those results by showing a three-way interaction with genetic modifiers of response to oxidative stress.</p><p>Although particle exposure has also been linked with activation of inflammatory pathways (<xref ref-type="bibr" rid="b2-ehp0115-001617">Baccarelli et al. 2007b</xref>; <xref ref-type="bibr" rid="b22-ehp0115-001617">Liao et al. 2004</xref>; <xref ref-type="bibr" rid="b32-ehp0115-001617">Peters et al. 2001</xref>), alterations in blood coagulation (<xref ref-type="bibr" rid="b1-ehp0115-001617">Baccarelli et al. 2007a</xref>; <xref ref-type="bibr" rid="b23-ehp0115-001617">Liao et al. 2005</xref>), endothelial injury and dysfunction (<xref ref-type="bibr" rid="b4-ehp0115-001617">Brook et al. 2002</xref>; <xref ref-type="bibr" rid="b19-ehp0115-001617">Ikeda et al. 1998</xref>), and alterations in the autonomic control of the heart (<xref ref-type="bibr" rid="b7-ehp0115-001617">Creason et al. 2001</xref>; <xref ref-type="bibr" rid="b14-ehp0115-001617">Gold et al. 2000</xref>; <xref ref-type="bibr" rid="b22-ehp0115-001617">Liao et al. 2004a</xref>), our findings suggest that genetic variations in oxidative stress pathways play a critical role in the cardiovascular effects of airborne particles.</p><p>Rodents exposed to concentrated urban particles evinced increased reactive oxygen species in both the lung and the heart (<xref ref-type="bibr" rid="b15-ehp0115-001617">Gurgueira et al. 2002</xref>), an effect muted by preadministration of <italic>N</italic>-acetylcysteine, a glutathione precursor and potent antioxidant (<xref ref-type="bibr" rid="b34-ehp0115-001617">Rhoden et al. 2004</xref>). Inhalation of particles produces oxidative stress directly or via acute pulmonary inflammation, thus causing a series of events, such as the production of proinflammatory mediators, an increase of extracellular calcium influx, and the disruption of nitric oxide regulation (<xref ref-type="bibr" rid="b41-ehp0115-001617">Stone et al. 2000</xref>; <xref ref-type="bibr" rid="b43-ehp0115-001617">Thomas et al. 2001</xref>), that may impair autonomic function and hence HRV. Diesel particles have also been shown to increase oxidative stress in endothelial tissue, inducing the production of HMOX-1 (<xref ref-type="bibr" rid="b13-ehp0115-001617">Furuyama et al. 2006</xref>). The viability of cell cultures of microvascular endothelial cells was impaired by diesel particles with an accompanying large increase in induction of HMOX-1 (<xref ref-type="bibr" rid="b17-ehp0115-001617">Hirano et al. 2003</xref>); this process was blunted by <italic>N</italic>-acetylcysteine. Woodsmoke particles have also been shown to deplete intracellular glutathione and upregulate HMOX-1 activity in endothelial cells (<xref ref-type="bibr" rid="b24-ehp0115-001617">Liu et al. 2005</xref>). Our results showing interactions of particles with <italic>GSTM1</italic> deletion and microsatellite (GT)n repeat length in the gene coding for HMOX-1 are consistent with these laboratory findings that suggest a prominent role of ROS in particle toxicity.</p><p>HMOX-1, the inducible heme oxygenase isoform, is expressed in multiple tissues, including vascular smooth muscle and endothelial cells (<xref ref-type="bibr" rid="b11-ehp0115-001617">Exner et al. 2004</xref>). <italic>HMOX-1</italic> expression has been shown to be upregulated in rat heart microvessel endothelial cells exposed to organic extracts of diesel exhaust particles (<xref ref-type="bibr" rid="b13-ehp0115-001617">Furuyama et al. 2006</xref>), an effect that is likely to represent a response directed against ROS production (<xref ref-type="bibr" rid="b27-ehp0115-001617">Morita 2005</xref>). Large individual differences in the ability to modulate the quantitative level of HMOX-1 activity in response to a given stimulus have been described, which correlate with differences in the length of a microsatellite (GT)n repeat in the 5&#x02032; flanking region of the <italic>HMOX-1</italic> gene (<xref ref-type="bibr" rid="b11-ehp0115-001617">Exner et al. 2004</xref>; <xref ref-type="bibr" rid="b16-ehp0115-001617">Hirai et al. 2003</xref>; <xref ref-type="bibr" rid="b47-ehp0115-001617">Yamada et al. 2000</xref>). The purine&#x02013;pyrimidine alternating sequence in the (GT)n repeat has the potential to assume Z-DNA conformation, a left-handed double-helix structure that is thermodynamically unfavorable compared with B-DNA conformation (<xref ref-type="bibr" rid="b35-ehp0115-001617">Rich et al. 1984</xref>) and has been described as negatively affecting transcriptional activity (<xref ref-type="bibr" rid="b8-ehp0115-001617">Delic et al. 1991</xref>; <xref ref-type="bibr" rid="b28-ehp0115-001617">Naylor and Clark 1990</xref>). Yamada and co-workers demonstrated by transient-transfection assay in cultured cell lines that the larger the number of (GT)n repeats in the <italic>HMOX-1</italic> gene promoter, the lower is the <italic>HMOX-1</italic> inducibility by ROS (<xref ref-type="bibr" rid="b47-ehp0115-001617">Yamada et al. 2000</xref>).</p><p>In our study, <italic>HMOX-1</italic> microsatellite (GT)n repeat length appeared to modulate the effects of PM<sub>2.5</sub> on autonomic function, as measured by HRV variability. PM<sub>2.5</sub> exhibited a negative correlation with SDNN, HF, and LF in individuals with &#x02265; 25 repeats, whereas no effect was seen in subjects with &#x0003c; 25 repeats. Furthermore, the strongest effects of PM<sub>2.5</sub> were found in subjects that were lacking efficiency in antioxidant responses due to the combination of the <italic>GSTM1</italic> deletion and &#x02265; 25 microsatellite (GT)n repeats in the <italic>HMOX-1</italic> promoter. While the <italic>p</italic>-values for statistical interaction between PM<sub>2.5</sub> and <italic>GSTM1</italic> and between PM<sub>2.5</sub> and <italic>HMOX-1</italic> were not significant, the tests for the three-way interaction among PM<sub>2.5</sub>, <italic>GSTM1</italic>, and <italic>HMOX-1</italic> were highly significant, confirming that the stronger effect modification of PM<sub>2.5</sub> effects on HRV is seen when both genes are considered. The statistical modeling we used to fit the three-way interaction tested whether the size of PM<sub>2.5</sub> effects in carriers of <italic>GSTM1</italic> null and at least one long <italic>HMOX-1</italic> repeat was 2 times larger than that observed in subjects carrying either <italic>GSTM1</italic> null or one long <italic>HMOX-1</italic> repeat. Thus, our data strongly suggest that particle exposure interacts with individual variations in the antioxidant response pathway to determine its effects on HRV.</p><p>A potential limitation of this study is that we used ambient PM<sub>2.5</sub> concentrations from a single monitoring site as a surrogate for recent exposure to PM<sub>2.5</sub>. A recent study comparing ambient concentrations at this site with personal exposures in Boston has shown a high longitudinal correlation (<xref ref-type="bibr" rid="b37-ehp0115-001617">Sarnat et al. 2005</xref>) between the two measurements; the study also reported that PM<sub>2.5</sub> concentrations were spatially homogeneous over the Boston area. This suggests that our use of ambient concentrations is reasonable and the resulting exposure error is likely to be nondifferential. In our analyses, we considered several potential confounding factors that may have influenced HRV measures, as we adjusted our models for age, BMI, mean arterial pressure, fasting blood glucose, cigarette smoking, alcohol consumption, room temperature, outdoor apparent temperature, season, and use of beta-blockers, calcium channel blockers, and ACE inhibitors. Therefore, chances that the observed associations reflected bias due to confounders are minimized.</p><p>Our results can be generalized only to an aged population that consists of older males who are almost all white. The effect on women and children as well as different ethnic groups should be addressed in future studies, particularly in relation to the exposure of different population groups to PM<sub>2.5</sub> with varying geographic location, occupation, socioeconomic status, and behavioral characteristics. Other health outcomes including respiratory responses may also be affected by responses to ROS in an interaction with PM<sub>2.5</sub> exposure. Our findings provide new information to guide research on the breadth of the effect of PM<sub>2.5</sub> exposure.</p></sec></body><back><fn-group><fn><p>This work was supported by National Institute of Environmental Health Sciences grants RO1ES00002, RO1ES015172-01, PO1ES009825, and U.S. Environmental Protection Agency grants EPAR827353 and R83241601. The VA Normative Aging Study, a component of the Massachusetts Veterans Epidemiology Research and Information Center, Boston, Massachusetts, is supported by the Cooperative Studies Program/Epidemiology Research and Information Center of the U.S. Department of Veterans Affairs.</p></fn></fn-group><ref-list><title>References</title><ref id="b1-ehp0115-001617"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baccarelli</surname><given-names>A</given-names></name><name><surname>Zanobetti</surname><given-names>A</given-names></name><name><surname>Martinelli</surname><given-names>I</given-names></name><name><surname>Grillo</surname><given-names>P</given-names></name><name><surname>Hou</surname><given-names>L</given-names></name><name><surname>Giacomini</surname><given-names>S</given-names></name><etal/></person-group><year>2007a</year><article-title>Effects of exposure to air pollution on blood coagulation</article-title><source>J Thromb Haemost</source><volume>5</volume><fpage>252</fpage><lpage>260</lpage><pub-id pub-id-type="pmid">17083648</pub-id></citation></ref><ref id="b2-ehp0115-001617"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baccarelli</surname><given-names>A</given-names></name><name><surname>Zanobetti</surname><given-names>A</given-names></name><name><surname>Martinelli</surname><given-names>I</given-names></name><name><surname>Grillo</surname><given-names>P</given-names></name><name><surname>Hou</surname><given-names>L</given-names></name><name><surname>Lanzani</surname><given-names>G</given-names></name><etal/></person-group><year>2007b</year><article-title>Air pollution, smoking, and plasma homocysteine</article-title><source>Environ Health Perspect</source><volume>115</volume><fpage>176</fpage><lpage>181</lpage><pub-id pub-id-type="pmid">17384761</pub-id></citation></ref><ref id="b3-ehp0115-001617"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bell</surname><given-names>B</given-names></name><name><surname>Rose</surname><given-names>C</given-names></name><name><surname>Damon</surname><given-names>A</given-names></name></person-group><year>1972</year><article-title>The normative aging study: an interdisciplinary and longitudinal study of health and aging</article-title><source>Aging Hum Dev</source><volume>3</volume><fpage>4</fpage><lpage>17</lpage></citation></ref><ref id="b4-ehp0115-001617"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brook</surname><given-names>RD</given-names></name><name><surname>Brook</surname><given-names>JR</given-names></name><name><surname>Urch</surname><given-names>B</given-names></name><name><surname>Vincent</surname><given-names>R</given-names></name><name><surname>Rajagopalan</surname><given-names>S</given-names></name><name><surname>Silverman</surname><given-names>F</given-names></name></person-group><year>2002</year><article-title>Inhalation of fine particulate air pollution and ozone causes acute arterial vasoconstriction in healthy adults</article-title><source>Circulation</source><volume>105</volume><fpage>1534</fpage><lpage>1536</lpage><pub-id pub-id-type="pmid">11927516</pub-id></citation></ref><ref id="b5-ehp0115-001617"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brook</surname><given-names>RD</given-names></name><name><surname>Franklin</surname><given-names>B</given-names></name><name><surname>Cascio</surname><given-names>W</given-names></name><name><surname>Hong</surname><given-names>Y</given-names></name><name><surname>Howard</surname><given-names>G</given-names></name><name><surname>Lipsett</surname><given-names>M</given-names></name><etal/></person-group><year>2004</year><article-title>Air pollution and cardiovascular disease: a statement for healthcare professionals from the Expert Panel on Population and Prevention Science of the American Heart Association</article-title><source>Circulation</source><volume>109</volume><fpage>2655</fpage><lpage>2671</lpage><pub-id pub-id-type="pmid">15173049</pub-id></citation></ref><ref id="b6-ehp0115-001617"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>YH</given-names></name><name><surname>Lin</surname><given-names>SJ</given-names></name><name><surname>Lin</surname><given-names>MW</given-names></name><name><surname>Tsai</surname><given-names>HL</given-names></name><name><surname>Kuo</surname><given-names>SS</given-names></name><name><surname>Chen</surname><given-names>JW</given-names></name><etal/></person-group><year>2002</year><article-title>Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients</article-title><source>Hum Genet</source><volume>111</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">12136229</pub-id></citation></ref><ref id="b7-ehp0115-001617"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Creason</surname><given-names>J</given-names></name><name><surname>Neas</surname><given-names>L</given-names></name><name><surname>Walsh</surname><given-names>D</given-names></name><name><surname>Williams</surname><given-names>R</given-names></name><name><surname>Sheldon</surname><given-names>L</given-names></name><name><surname>Liao</surname><given-names>D</given-names></name><etal/></person-group><year>2001</year><article-title>Particulate matter and heart rate variability among elderly retirees: the Baltimore 1998 PM study</article-title><source>J Expo Anal Environ Epidemiol</source><volume>11</volume><fpage>116</fpage><lpage>122</lpage><pub-id pub-id-type="pmid">11409004</pub-id></citation></ref><ref id="b8-ehp0115-001617"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Delic</surname><given-names>J</given-names></name><name><surname>Onclercq</surname><given-names>R</given-names></name><name><surname>Moisan-Coppey</surname><given-names>M</given-names></name></person-group><year>1991</year><article-title>Inhibition and enhancement of eukaryotic gene expression by potential non-B DNA sequences</article-title><source>Biochem Biophys Res Commun</source><volume>181</volume><fpage>818</fpage><lpage>826</lpage><pub-id pub-id-type="pmid">1755861</pub-id></citation></ref><ref id="b9-ehp0115-001617"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Devlin</surname><given-names>RB</given-names></name><name><surname>Ghio</surname><given-names>AJ</given-names></name><name><surname>Kehrl</surname><given-names>H</given-names></name><name><surname>Sanders</surname><given-names>G</given-names></name><name><surname>Cascio</surname><given-names>W</given-names></name></person-group><year>2003</year><article-title>Elderly humans exposed to concentrated air pollution particles have decreased heart rate variability</article-title><source>Eur Respir J Suppl</source><volume>40</volume><fpage>76s</fpage><lpage>80s</lpage><pub-id pub-id-type="pmid">12762579</pub-id></citation></ref><ref id="b10-ehp0115-001617"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dhalla</surname><given-names>NS</given-names></name><name><surname>Temsah</surname><given-names>RM</given-names></name><name><surname>Netticadan</surname><given-names>T</given-names></name></person-group><year>2000</year><article-title>Role of oxidative stress in cardiovascular diseases</article-title><source>J Hypertens</source><volume>18</volume><fpage>655</fpage><lpage>673</lpage><pub-id pub-id-type="pmid">10872549</pub-id></citation></ref><ref id="b11-ehp0115-001617"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Exner</surname><given-names>M</given-names></name><name><surname>Minar</surname><given-names>E</given-names></name><name><surname>Wagner</surname><given-names>O</given-names></name><name><surname>Schillinger</surname><given-names>M</given-names></name></person-group><year>2004</year><article-title>The role of heme oxygenase-1 promoter polymorphisms in human disease</article-title><source>Free Radic Biol Med</source><volume>37</volume><fpage>1097</fpage><lpage>1104</lpage><pub-id pub-id-type="pmid">15451051</pub-id></citation></ref><ref id="b12-ehp0115-001617"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Forastiere</surname><given-names>F</given-names></name><name><surname>Stafoggia</surname><given-names>M</given-names></name><name><surname>Picciotto</surname><given-names>S</given-names></name><name><surname>Bellander</surname><given-names>T</given-names></name><name><surname>D&#x02019;Ippoliti</surname><given-names>D</given-names></name><name><surname>Lanki</surname><given-names>T</given-names></name><etal/></person-group><year>2005</year><article-title>A case-crossover analysis of out-of-hospital coronary deaths and air pollution in Rome, Italy</article-title><source>Am J Respir Crit Care Med</source><volume>172</volume><fpage>1549</fpage><lpage>1555</lpage><pub-id pub-id-type="pmid">15994461</pub-id></citation></ref><ref id="b13-ehp0115-001617"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Furuyama</surname><given-names>A</given-names></name><name><surname>Hirano</surname><given-names>S</given-names></name><name><surname>Koike</surname><given-names>E</given-names></name><name><surname>Kobayashi</surname><given-names>T</given-names></name></person-group><year>2006</year><article-title>Induction of oxidative stress and inhibition of plasminogen activator inhibitor-1 production in endothelial cells following exposure to organic extracts of diesel exhaust particles and urban fine particles</article-title><source>Arch Toxicol</source><volume>80</volume><fpage>154</fpage><lpage>162</lpage><pub-id pub-id-type="pmid">16180011</pub-id></citation></ref><ref id="b14-ehp0115-001617"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gold</surname><given-names>DR</given-names></name><name><surname>Litonjua</surname><given-names>A</given-names></name><name><surname>Schwartz</surname><given-names>J</given-names></name><name><surname>Lovett</surname><given-names>E</given-names></name><name><surname>Larson</surname><given-names>A</given-names></name><name><surname>Nearing</surname><given-names>B</given-names></name><etal/></person-group><year>2000</year><article-title>Ambient pollution and heart rate variability</article-title><source>Circulation</source><volume>101</volume><fpage>1267</fpage><lpage>1273</lpage><pub-id pub-id-type="pmid">10725286</pub-id></citation></ref><ref id="b15-ehp0115-001617"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gurgueira</surname><given-names>SA</given-names></name><name><surname>Lawrence</surname><given-names>J</given-names></name><name><surname>Coull</surname><given-names>B</given-names></name><name><surname>Murthy</surname><given-names>GG</given-names></name><name><surname>Gonzalez-Flecha</surname><given-names>B</given-names></name></person-group><year>2002</year><article-title>Rapid increases in the steady-state concentration of reactive oxygen species in the lungs and heart after particulate air pollution inhalation</article-title><source>Environ Health Perspect</source><volume>110</volume><fpage>749</fpage><lpage>755</lpage><pub-id pub-id-type="pmid">12153754</pub-id></citation></ref><ref id="b16-ehp0115-001617"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hirai</surname><given-names>H</given-names></name><name><surname>Kubo</surname><given-names>H</given-names></name><name><surname>Yamaya</surname><given-names>M</given-names></name><name><surname>Nakayama</surname><given-names>K</given-names></name><name><surname>Numasaki</surname><given-names>M</given-names></name><name><surname>Kobayashi</surname><given-names>S</given-names></name><etal/></person-group><year>2003</year><article-title>Microsatellite polymorphism in heme oxygenase-1 gene promoter is associated with susceptibility to oxidant-induced apoptosis in lymphoblastoid cell lines</article-title><source>Blood</source><volume>102</volume><fpage>1619</fpage><lpage>1621</lpage><pub-id pub-id-type="pmid">12730098</pub-id></citation></ref><ref id="b17-ehp0115-001617"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hirano</surname><given-names>S</given-names></name><name><surname>Furuyama</surname><given-names>A</given-names></name><name><surname>Koike</surname><given-names>E</given-names></name><name><surname>Kobayashi</surname><given-names>T</given-names></name></person-group><year>2003</year><article-title>Oxidative-stress potency of organic extracts of diesel exhaust and urban fine particles in rat heart microvessel endothelial cells</article-title><source>Toxicology</source><volume>187</volume><fpage>161</fpage><lpage>170</lpage><pub-id pub-id-type="pmid">12699905</pub-id></citation></ref><ref id="b18-ehp0115-001617"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Holguin</surname><given-names>F</given-names></name><name><surname>Tellez-Rojo</surname><given-names>MM</given-names></name><name><surname>Hernandez</surname><given-names>M</given-names></name><name><surname>Cortez</surname><given-names>M</given-names></name><name><surname>Chow</surname><given-names>JC</given-names></name><name><surname>Watson</surname><given-names>JG</given-names></name><etal/></person-group><year>2003</year><article-title>Air pollution and heart rate variability among the elderly in Mexico City</article-title><source>Epidemiology</source><volume>14</volume><fpage>521</fpage><lpage>527</lpage><pub-id pub-id-type="pmid">14501266</pub-id></citation></ref><ref id="b19-ehp0115-001617"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ikeda</surname><given-names>M</given-names></name><name><surname>Watarai</surname><given-names>K</given-names></name><name><surname>Suzuki</surname><given-names>M</given-names></name><name><surname>Ito</surname><given-names>T</given-names></name><name><surname>Yamasaki</surname><given-names>H</given-names></name><name><surname>Sagai</surname><given-names>M</given-names></name><etal/></person-group><year>1998</year><article-title>Mechanism of pathophysiological effects of diesel exhaust particles on endothelial cells</article-title><source>Environ Toxicol Pharmacol</source><volume>6</volume><fpage>117</fpage><lpage>123</lpage></citation></ref><ref id="b20-ehp0115-001617"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kaneda</surname><given-names>H</given-names></name><name><surname>Ohno</surname><given-names>M</given-names></name><name><surname>Taguchi</surname><given-names>J</given-names></name><name><surname>Togo</surname><given-names>M</given-names></name><name><surname>Hashimoto</surname><given-names>H</given-names></name><name><surname>Ogasawara</surname><given-names>K</given-names></name><etal/></person-group><year>2002</year><article-title>Heme oxygenase-1 gene promoter polymorphism is associated with coronary artery disease in Japanese patients with coronary risk factors</article-title><source>Arterioscler Thromb Vasc Biol</source><volume>22</volume><fpage>1680</fpage><lpage>1685</lpage><pub-id pub-id-type="pmid">12377749</pub-id></citation></ref><ref id="b21-ehp0115-001617"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>N</given-names></name><name><surname>Alam</surname><given-names>J</given-names></name><name><surname>Venkatesan</surname><given-names>MI</given-names></name><name><surname>Eiguren-Fernandez</surname><given-names>A</given-names></name><name><surname>Schmitz</surname><given-names>D</given-names></name><name><surname>Di Stefano</surname><given-names>E</given-names></name><etal/></person-group><year>2004</year><article-title>Nrf2 is a key transcription factor that regulates antioxidant defense in macrophages and epithelial cells: protecting against the proinflammatory and oxidizing effects of diesel exhaust chemicals</article-title><source>J Immunol</source><volume>173</volume><fpage>3467</fpage><lpage>3481</lpage><pub-id pub-id-type="pmid">15322212</pub-id></citation></ref><ref id="b22-ehp0115-001617"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>D</given-names></name><name><surname>Duan</surname><given-names>Y</given-names></name><name><surname>Whitsel</surname><given-names>EA</given-names></name><name><surname>Zheng</surname><given-names>ZJ</given-names></name><name><surname>Heiss</surname><given-names>G</given-names></name><name><surname>Chinchilli</surname><given-names>VM</given-names></name><etal/></person-group><year>2004</year><article-title>Association of higher levels of ambient criteria pollutants with impaired cardiac autonomic control: a population-based study</article-title><source>Am J Epidemiol</source><volume>159</volume><fpage>768</fpage><lpage>777</lpage><pub-id pub-id-type="pmid">15051586</pub-id></citation></ref><ref id="b23-ehp0115-001617"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>D</given-names></name><name><surname>Heiss</surname><given-names>G</given-names></name><name><surname>Chinchilli</surname><given-names>VM</given-names></name><name><surname>Duan</surname><given-names>Y</given-names></name><name><surname>Folsom</surname><given-names>AR</given-names></name><name><surname>Lin</surname><given-names>HM</given-names></name><etal/></person-group><year>2005</year><article-title>Association of criteria pollutants with plasma hemostatic/inflammatory markers: a population-based study</article-title><source>J Expo Anal Environ Epidemiol</source><volume>15</volume><issue>4</issue><fpage>319</fpage><lpage>328</lpage><pub-id pub-id-type="pmid">15536489</pub-id></citation></ref><ref id="b24-ehp0115-001617"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>PL</given-names></name><name><surname>Chen</surname><given-names>YL</given-names></name><name><surname>Chen</surname><given-names>YH</given-names></name><name><surname>Lin</surname><given-names>SJ</given-names></name><name><surname>Kou</surname><given-names>YR</given-names></name></person-group><year>2005</year><article-title>Wood smoke extract induces oxidative stress-mediated caspase-independent apoptosis in human lung endothelial cells: role of AIF and EndoG</article-title><source>Am J Physiol Lung Cell Mol Physiol</source><volume>289</volume><fpage>L739</fpage><lpage>L749</lpage><pub-id pub-id-type="pmid">15964899</pub-id></citation></ref><ref id="b25-ehp0115-001617"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Magari</surname><given-names>SR</given-names></name><name><surname>Schwartz</surname><given-names>J</given-names></name><name><surname>Williams</surname><given-names>PL</given-names></name><name><surname>Hauser</surname><given-names>R</given-names></name><name><surname>Smith</surname><given-names>TJ</given-names></name><name><surname>Christiani</surname><given-names>DC</given-names></name></person-group><year>2002</year><article-title>The association of particulate air metal concentrations with heart rate variability</article-title><source>Environ Health Perspect</source><volume>110</volume><fpage>875</fpage><lpage>880</lpage><pub-id pub-id-type="pmid">12204821</pub-id></citation></ref><ref id="b26-ehp0115-001617"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Millstein</surname><given-names>J</given-names></name><name><surname>Conti</surname><given-names>DV</given-names></name><name><surname>Gilliland</surname><given-names>FD</given-names></name><name><surname>Gauderman</surname><given-names>WJ</given-names></name></person-group><year>2006</year><article-title>A testing framework for identifying susceptibility genes in the presence of epistasis</article-title><source>Am J Hum Genet</source><volume>78</volume><fpage>15</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">16385446</pub-id></citation></ref><ref id="b27-ehp0115-001617"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morita</surname><given-names>T</given-names></name></person-group><year>2005</year><article-title>Heme oxygenase and atherosclerosis</article-title><source>Arterioscler Thromb Vasc Biol</source><volume>25</volume><fpage>1786</fpage><lpage>1795</lpage><pub-id pub-id-type="pmid">16020746</pub-id></citation></ref><ref id="b28-ehp0115-001617"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Naylor</surname><given-names>LH</given-names></name><name><surname>Clark</surname><given-names>EM</given-names></name></person-group><year>1990</year><article-title>d(TG)n.d(CA)n sequences upstream of the rat prolactin gene form Z-DNA and inhibit gene transcription</article-title><source>Nucleic Acids Res</source><volume>18</volume><fpage>1595</fpage><lpage>1601</lpage><pub-id pub-id-type="pmid">2158081</pub-id></citation></ref><ref id="b29-ehp0115-001617"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nel</surname><given-names>A</given-names></name></person-group><year>2005</year><article-title>Atmosphere. Air pollution-related illness: effects of particles</article-title><source>Science</source><volume>308</volume><fpage>804</fpage><lpage>806</lpage><pub-id pub-id-type="pmid">15879201</pub-id></citation></ref><ref id="b30-ehp0115-001617"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>SK</given-names></name><name><surname>O&#x02019;Neill</surname><given-names>MS</given-names></name><name><surname>Vokonas</surname><given-names>PS</given-names></name><name><surname>Sparrow</surname><given-names>D</given-names></name><name><surname>Schwartz</surname><given-names>J</given-names></name></person-group><year>2005</year><article-title>Effects of air pollution on heart rate variability: the VA normative aging study</article-title><source>Environ Health Perspect</source><volume>113</volume><fpage>304</fpage><lpage>309</lpage><pub-id pub-id-type="pmid">15743719</pub-id></citation></ref><ref id="b31-ehp0115-001617"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>SK</given-names></name><name><surname>O&#x02019;Neill</surname><given-names>MS</given-names></name><name><surname>Wright</surname><given-names>RO</given-names></name><name><surname>Hu</surname><given-names>H</given-names></name><name><surname>Vokonas</surname><given-names>PS</given-names></name><name><surname>Sparrow</surname><given-names>D</given-names></name><etal/></person-group><year>2006</year><article-title>HFE genotype, particulate air pollution, and heart rate variability: a gene-environment interaction</article-title><source>Circulation</source><volume>114</volume><fpage>2798</fpage><lpage>2805</lpage><pub-id pub-id-type="pmid">17145987</pub-id></citation></ref><ref id="b32-ehp0115-001617"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peters</surname><given-names>A</given-names></name><name><surname>Frohlich</surname><given-names>M</given-names></name><name><surname>Doring</surname><given-names>A</given-names></name><name><surname>Immervoll</surname><given-names>T</given-names></name><name><surname>Wichmann</surname><given-names>HE</given-names></name><name><surname>Hutchinson</surname><given-names>WL</given-names></name><etal/></person-group><year>2001</year><article-title>Particulate air pollution is associated with an acute phase response in men; results from the MONICA-Augsburg Study</article-title><source>Eur Heart J</source><volume>22</volume><fpage>1198</fpage><lpage>1204</lpage><pub-id pub-id-type="pmid">11440492</pub-id></citation></ref><ref id="b33-ehp0115-001617"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pope</surname><given-names>CA</given-names><suffix>III</suffix></name><name><surname>Hansen</surname><given-names>ML</given-names></name><name><surname>Long</surname><given-names>RW</given-names></name><name><surname>Nielsen</surname><given-names>KR</given-names></name><name><surname>Eatough</surname><given-names>NL</given-names></name><name><surname>Wilson</surname><given-names>WE</given-names></name><etal/></person-group><year>2004</year><article-title>Ambient particulate air pollution, heart rate variability, and blood markers of inflammation in a panel of elderly subjects</article-title><source>Environ Health Perspect</source><volume>112</volume><fpage>339</fpage><lpage>345</lpage><pub-id pub-id-type="pmid">14998750</pub-id></citation></ref><ref id="b34-ehp0115-001617"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rhoden</surname><given-names>CR</given-names></name><name><surname>Lawrence</surname><given-names>J</given-names></name><name><surname>Godleski</surname><given-names>JJ</given-names></name><name><surname>Gonzalez-Flecha</surname><given-names>B</given-names></name></person-group><year>2004</year><article-title><italic>N</italic>-acetylcysteine prevents lung inflammation after short-term inhalation exposure to concentrated ambient particles</article-title><source>Toxicol Sci</source><volume>79</volume><fpage>296</fpage><lpage>303</lpage><pub-id pub-id-type="pmid">15056806</pub-id></citation></ref><ref id="b35-ehp0115-001617"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rich</surname><given-names>A</given-names></name><name><surname>Nordheim</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>AH</given-names></name></person-group><year>1984</year><article-title>The chemistry and biology of left-handed Z-DNA</article-title><source>Annu Rev Biochem</source><volume>53</volume><fpage>791</fpage><lpage>846</lpage><pub-id pub-id-type="pmid">6383204</pub-id></citation></ref><ref id="b36-ehp0115-001617"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Samet</surname><given-names>JM</given-names></name><name><surname>Zeger</surname><given-names>SL</given-names></name><name><surname>Dominici</surname><given-names>F</given-names></name><name><surname>Curriero</surname><given-names>F</given-names></name><name><surname>Coursac</surname><given-names>I</given-names></name><name><surname>Dockery</surname><given-names>DW</given-names></name><etal/></person-group><year>2000</year><article-title>The National Morbidity, Mortality, and Air Pollution Study. Part II: Morbidity and mortality from air pollution in the United States</article-title><source>Res Rep Health Eff Inst</source><volume>94</volume><fpage>5</fpage><lpage>70</lpage></citation></ref><ref id="b37-ehp0115-001617"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sarnat</surname><given-names>JA</given-names></name><name><surname>Brown</surname><given-names>KW</given-names></name><name><surname>Schwartz</surname><given-names>J</given-names></name><name><surname>Coull</surname><given-names>BA</given-names></name><name><surname>Koutrakis</surname><given-names>P</given-names></name></person-group><year>2005</year><article-title>Ambient gas concentrations and personal particulate matter exposures: implications for studying the health effects of particles</article-title><source>Epidemiology</source><volume>16</volume><fpage>385</fpage><lpage>395</lpage><pub-id pub-id-type="pmid">15824556</pub-id></citation></ref><ref id="b38-ehp0115-001617"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>J</given-names></name></person-group><year>1999</year><article-title>Air pollution and hospital admissions for heart disease in eight U.S. counties</article-title><source>Epidemiology</source><volume>10</volume><fpage>17</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">9888275</pub-id></citation></ref><ref id="b39-ehp0115-001617"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>J</given-names></name><name><surname>Litonjua</surname><given-names>A</given-names></name><name><surname>Suh</surname><given-names>H</given-names></name><name><surname>Verrier</surname><given-names>M</given-names></name><name><surname>Zanobetti</surname><given-names>A</given-names></name><name><surname>Syring</surname><given-names>M</given-names></name><etal/></person-group><year>2005a</year><article-title>Traffic related pollution and heart rate variability in a panel of elderly subjects</article-title><source>Thorax</source><volume>60</volume><fpage>455</fpage><lpage>461</lpage><pub-id pub-id-type="pmid">15923244</pub-id></citation></ref><ref id="b40-ehp0115-001617"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>J</given-names></name><name><surname>Park</surname><given-names>SK</given-names></name><name><surname>O&#x02019;Neill</surname><given-names>M S</given-names></name><name><surname>Vokonas</surname><given-names>PS</given-names></name><name><surname>Sparrow</surname><given-names>D</given-names></name><name><surname>Weiss</surname><given-names>S</given-names></name><etal/></person-group><year>2005b</year><article-title>Glutathione-S-transferase M1, obesity, statins, and autonomic effects of particles: gene-by-drug-by-environment interaction</article-title><source>Am J Respir Crit Care Med</source><volume>172</volume><fpage>1529</fpage><lpage>1533</lpage><pub-id pub-id-type="pmid">16020798</pub-id></citation></ref><ref id="b41-ehp0115-001617"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stone</surname><given-names>V</given-names></name><name><surname>Tuinman</surname><given-names>M</given-names></name><name><surname>Vamvakopoulos</surname><given-names>JE</given-names></name><name><surname>Shaw</surname><given-names>J</given-names></name><name><surname>Brown</surname><given-names>D</given-names></name><name><surname>Petterson</surname><given-names>S</given-names></name><etal/></person-group><year>2000</year><article-title>Increased calcium influx in a monocytic cell line on exposure to ultrafine carbon black</article-title><source>Eur Respir J</source><volume>15</volume><fpage>297</fpage><lpage>303</lpage><pub-id pub-id-type="pmid">10706495</pub-id></citation></ref><ref id="b42-ehp0115-001617"><citation citation-type="journal"><collab>Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology</collab><year>1996</year><article-title>Heart rate variability. Standards of measurement, physiological interpretation, and clinical use</article-title><source>Eur Heart J</source><volume>17</volume><fpage>354</fpage><lpage>381</lpage><pub-id pub-id-type="pmid">8737210</pub-id></citation></ref><ref id="b43-ehp0115-001617"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>GD</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Victor</surname><given-names>RG</given-names></name></person-group><year>2001</year><article-title>Impaired modulation of sympathetic vasoconstriction in contracting skeletal muscle of rats with chronic myocardial infarctions: role of oxidative stress</article-title><source>Circ Res</source><volume>88</volume><fpage>816</fpage><lpage>823</lpage><pub-id pub-id-type="pmid">11325874</pub-id></citation></ref><ref id="b44-ehp0115-001617"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tsuji</surname><given-names>H</given-names></name><name><surname>Larson</surname><given-names>MG</given-names></name><name><surname>Venditti</surname><given-names>FJ</given-names><suffix>Jr</suffix></name><name><surname>Manders</surname><given-names>ES</given-names></name><name><surname>Evans</surname><given-names>JC</given-names></name><name><surname>Feldman</surname><given-names>CL</given-names></name><etal/></person-group><year>1996</year><article-title>Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study</article-title><source>Circulation</source><volume>94</volume><fpage>2850</fpage><lpage>2855</lpage><pub-id pub-id-type="pmid">8941112</pub-id></citation></ref><ref id="b45-ehp0115-001617"><citation citation-type="book"><collab>Unigene</collab><year>2007a</year><source>Glutathione S-Transferase M1</source><publisher-loc>Bethesda, MD</publisher-loc><publisher-name>National Center for Biotechnology Information</publisher-name><comment>Available: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/UniGene/clust.cgi?UGID=181321&#x00026;TAXID=9606&#x00026;SEARCH=gstm1">http://www.ncbi.nlm.nih.gov/UniGene/clust.cgi?UGID=181321&#x00026;TAXID=9606&#x00026;SEARCH=gstm1</ext-link></comment><access-date>[accessed 26 September 2007]</access-date></citation></ref><ref id="b46-ehp0115-001617"><citation citation-type="book"><collab>Unigene</collab><year>2007b</year><source>Heme Oxygenase (decycling) 1 (HMOX1)</source><publisher-loc>Bethesda, MD</publisher-loc><publisher-name>National Center for Biotechnology Information</publisher-name><comment>Available: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/UniGene/clust.cgi?UGID=908328&#x00026;TAXID=9606&#x00026;SEARCH=hmox1">http://www.ncbi.nlm.nih.gov/UniGene/clust.cgi?UGID=908328&#x00026;TAXID=9606&#x00026;SEARCH=hmox1</ext-link></comment><access-date>[accessed 26 September 2007]</access-date></citation></ref><ref id="b47-ehp0115-001617"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamada</surname><given-names>N</given-names></name><name><surname>Yamaya</surname><given-names>M</given-names></name><name><surname>Okinaga</surname><given-names>S</given-names></name><name><surname>Nakayama</surname><given-names>K</given-names></name><name><surname>Sekizawa</surname><given-names>K</given-names></name><name><surname>Shibahara</surname><given-names>S</given-names></name><etal/></person-group><year>2000</year><article-title>Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema</article-title><source>Am J Hum Genet</source><volume>66</volume><fpage>187</fpage><lpage>195</lpage><pub-id pub-id-type="pmid">10631150</pub-id></citation></ref><ref id="b48-ehp0115-001617"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zanobetti</surname><given-names>A</given-names></name><name><surname>Schwartz</surname><given-names>J</given-names></name></person-group><year>2005</year><article-title>The effect of particulate air pollution on emergency admissions for myocardial infarction: a multicity case-crossover analysis</article-title><source>Environ Health Perspect</source><volume>113</volume><fpage>978</fpage><lpage>982</lpage><pub-id pub-id-type="pmid">16079066</pub-id></citation></ref></ref-list></back><floats-wrap><fig id="f1-ehp0115-001617" position="float"><label>Figure 1</label><caption><p>Kernel density plot of subject-specific random slopes for the association of PM<sub>2.5</sub> level with SDNN, by <italic>GSTM1</italic> genotype and <italic>HMOX-1</italic> repeat length.</p></caption><graphic xlink:href="ehp0115-001617f1"/></fig><table-wrap id="t1-ehp0115-001617" position="float"><label>Table 1</label><caption><p>Anthropometric, clinical characteristics, and heart rate variability parameters [mean &#x000b1; SD or <italic>n</italic> (%)] of the study population, by <italic>GSTM1</italic> polymorphism status and <italic>HMOX-1</italic> microsatellite repeat length.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1"/><th colspan="4" align="center" rowspan="1">By <italic>GSTM1</italic> and <italic>HMOX-1</italic> polymorphisms (<italic>n</italic> = 476) <hr/></th></tr><tr><th align="left" rowspan="1" colspan="1">Variable</th><th align="center" rowspan="1" colspan="1">All subjects (<italic>n</italic> = 539)</th><th align="center" rowspan="1" colspan="1">All subjects analyzed for both <italic>HMOX-1</italic> and <italic>GSTM1</italic> (<italic>n</italic> = 476)</th><th align="center" rowspan="1" colspan="1"><italic>GSTM1</italic> wt <italic>HMOX-1</italic> &#x0003c; 25 repeats<xref ref-type="table-fn" rid="tfn2-ehp0115-001617">a</xref> (<italic>n</italic> = 20)</th><th align="center" rowspan="1" colspan="1"><italic>GSTM1</italic> null <italic>HMOX-1</italic> &#x0003c; 25 repeats<xref ref-type="table-fn" rid="tfn2-ehp0115-001617">a</xref> (<italic>n</italic> = 24)</th><th align="center" rowspan="1" colspan="1"><italic>GSTM1</italic> wt <italic>HMOX-1</italic> &#x02265; 25 repeats<xref ref-type="table-fn" rid="tfn3-ehp0115-001617">b</xref> (<italic>n</italic> = 204)</th><th align="center" rowspan="1" colspan="1"><italic>GSTM1</italic> null <italic>HMOX-1</italic> &#x02265; 25 repeats<xref ref-type="table-fn" rid="tfn3-ehp0115-001617">b</xref> (<italic>n</italic> = 228)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age (years)</td><td align="center" rowspan="1" colspan="1">72.8 &#x000b1; 6.6</td><td align="center" rowspan="1" colspan="1">73.0 &#x000b1; 6.7</td><td align="center" rowspan="1" colspan="1">72.5 &#x000b1; 4.8</td><td align="center" rowspan="1" colspan="1">73. 2 &#x000b1; 5.9</td><td align="center" rowspan="1" colspan="1">73.0 &#x000b1; 6.8</td><td align="center" rowspan="1" colspan="1">73.1 &#x000b1; 6.82</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td align="center" rowspan="1" colspan="1">28.2 &#x000b1; 4.1</td><td align="center" rowspan="1" colspan="1">28.0 &#x000b1; 4.1</td><td align="center" rowspan="1" colspan="1">27.8 &#x000b1; 4.7</td><td align="center" rowspan="1" colspan="1">28.3 &#x000b1; 3.3</td><td align="center" rowspan="1" colspan="1">28.1 &#x000b1; 4.4</td><td align="center" rowspan="1" colspan="1">28.0 &#x000b1; 3.90</td></tr><tr><td align="left" rowspan="1" colspan="1">Systolic blood pressure (mm Hg)</td><td align="center" rowspan="1" colspan="1">130.6 &#x000b1; 16.3</td><td align="center" rowspan="1" colspan="1">130.5 &#x000b1; 16.7</td><td align="center" rowspan="1" colspan="1">131.4 &#x000b1; 16.1</td><td align="center" rowspan="1" colspan="1">133.8 &#x000b1; 16.3</td><td align="center" rowspan="1" colspan="1">129.5 &#x000b1; 15.7</td><td align="center" rowspan="1" colspan="1">131.0 &#x000b1; 17.8</td></tr><tr><td align="left" rowspan="1" colspan="1">Diastolic blood pressure (mm Hg)</td><td align="center" rowspan="1" colspan="1">74.9 &#x000b1; 9.7</td><td align="center" rowspan="1" colspan="1">74.7 &#x000b1; 9.7</td><td align="center" rowspan="1" colspan="1">74.3 &#x000b1; 8.5</td><td align="center" rowspan="1" colspan="1">76.3 &#x000b1; 7.1</td><td align="center" rowspan="1" colspan="1">74.7 &#x000b1; 9.7</td><td align="center" rowspan="1" colspan="1">74.7 &#x000b1; 10.0</td></tr><tr><td align="left" rowspan="1" colspan="1">Mean arterial pressure (mm Hg)</td><td align="center" rowspan="1" colspan="1">93.5 &#x000b1; 10.6</td><td align="center" rowspan="1" colspan="1">93.3 &#x000b1; 10.7</td><td align="center" rowspan="1" colspan="1">93.3 &#x000b1; 9.5</td><td align="center" rowspan="1" colspan="1">95.5 &#x000b1; 8.6</td><td align="center" rowspan="1" colspan="1">92.9 &#x000b1; 10.5</td><td align="center" rowspan="1" colspan="1">93.4 &#x000b1; 11.2</td></tr><tr><td align="left" rowspan="1" colspan="1">Heart rate (beats/min)</td><td align="center" rowspan="1" colspan="1">70.7 &#x000b1; 6.8</td><td align="center" rowspan="1" colspan="1">71.0 &#x000b1; 6.8</td><td align="center" rowspan="1" colspan="1">72.0 &#x000b1; 4.6</td><td align="center" rowspan="1" colspan="1">70.6 &#x000b1; 6.5</td><td align="center" rowspan="1" colspan="1">70.5 &#x000b1; 6.8</td><td align="center" rowspan="1" colspan="1">71.2 &#x000b1; 7.1</td></tr><tr><td align="left" rowspan="1" colspan="1">Fasting blood glucose (mg/dL)</td><td align="center" rowspan="1" colspan="1">108.4 &#x000b1; 28.4</td><td align="center" rowspan="1" colspan="1">109.2 &#x000b1; 29.5</td><td align="center" rowspan="1" colspan="1">108.2 &#x000b1; 35.8</td><td align="center" rowspan="1" colspan="1">115.2 &#x000b1; 32.7</td><td align="center" rowspan="1" colspan="1">112.2 &#x000b1; 35.4</td><td align="center" rowspan="1" colspan="1">105.9 &#x000b1; 21.5</td></tr><tr><td align="left" rowspan="1" colspan="1">Total cholesterol (mg/dL)</td><td align="center" rowspan="1" colspan="1">194.9 &#x000b1; 36.7</td><td align="center" rowspan="1" colspan="1">194.8 &#x000b1; 37.3</td><td align="center" rowspan="1" colspan="1">187.3 &#x000b1; 32.9</td><td align="center" rowspan="1" colspan="1">202.3 &#x000b1; 37.8</td><td align="center" rowspan="1" colspan="1">196.7 &#x000b1; 35.3</td><td align="center" rowspan="1" colspan="1">192.9 &#x000b1; 39.3</td></tr><tr><td align="left" rowspan="1" colspan="1">HDL (mg/dL)</td><td align="center" rowspan="1" colspan="1">49.5 &#x000b1; 13.3</td><td align="center" rowspan="1" colspan="1">49.8 &#x000b1; 13.3</td><td align="center" rowspan="1" colspan="1">52.2 &#x000b1; 15.2</td><td align="center" rowspan="1" colspan="1">49.4 &#x000b1; 13.1</td><td align="center" rowspan="1" colspan="1">49.3 &#x000b1; 12.5</td><td align="center" rowspan="1" colspan="1">49.9 &#x000b1; 13.8</td></tr><tr><td align="left" rowspan="1" colspan="1">Triglyceride (mg/dL)</td><td align="center" rowspan="1" colspan="1">131.8 &#x000b1; 72.2</td><td align="center" rowspan="1" colspan="1">130.5 &#x000b1; 72.8</td><td align="center" rowspan="1" colspan="1">118.4 &#x000b1; 66.3</td><td align="center" rowspan="1" colspan="1">125.9 &#x000b1; 60.2</td><td align="center" rowspan="1" colspan="1">130.9 &#x000b1; 67.5</td><td align="center" rowspan="1" colspan="1">131.8 &#x000b1; 79.1</td></tr><tr><td colspan="7" align="left" rowspan="1">Smoking status [<italic>n</italic> (%)]</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Never smoker</td><td align="center" rowspan="1" colspan="1">165 (30.6)</td><td align="center" rowspan="1" colspan="1">145 (30.5)</td><td align="center" rowspan="1" colspan="1">6 (30.0)</td><td align="center" rowspan="1" colspan="1">5 (20.8)</td><td align="center" rowspan="1" colspan="1">71 (34.8)</td><td align="center" rowspan="1" colspan="1">63 (27.6)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Current smoker</td><td align="center" rowspan="1" colspan="1">27 (5.0)</td><td align="center" rowspan="1" colspan="1">23 (4.8)</td><td align="center" rowspan="1" colspan="1">3 (15.0)</td><td align="center" rowspan="1" colspan="1">2 (8.3)</td><td align="center" rowspan="1" colspan="1">6 (2.9)</td><td align="center" rowspan="1" colspan="1">12 (5.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Former smoker</td><td align="center" rowspan="1" colspan="1">347 (64.4)</td><td align="center" rowspan="1" colspan="1">308 (64.7)</td><td align="center" rowspan="1" colspan="1">11 (55.0)</td><td align="center" rowspan="1" colspan="1">17 (70.8)</td><td align="center" rowspan="1" colspan="1">127 (62.3)</td><td align="center" rowspan="1" colspan="1">153 (67.1)</td></tr><tr><td align="left" rowspan="1" colspan="1">Alcohol intake (&#x02265; 2 drinks/day) [<italic>n</italic> (%)]</td><td align="center" rowspan="1" colspan="1">102 (18.9)</td><td align="center" rowspan="1" colspan="1">89 (18.7)</td><td align="center" rowspan="1" colspan="1">2 (10.0)</td><td align="center" rowspan="1" colspan="1">4 (16.7)</td><td align="center" rowspan="1" colspan="1">42 (20.6)</td><td align="center" rowspan="1" colspan="1">41 (18.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">Diabetes mellitus, <italic>n</italic> (%)</td><td align="center" rowspan="1" colspan="1">80 (14.8)</td><td align="center" rowspan="1" colspan="1">75 (15.8)</td><td align="center" rowspan="1" colspan="1">5 (25.0)</td><td align="center" rowspan="1" colspan="1">6 (25.0)</td><td align="center" rowspan="1" colspan="1">38 (18.6)</td><td align="center" rowspan="1" colspan="1">26 (11.4)</td></tr><tr><td align="left" rowspan="1" colspan="1">CHD history [<italic>n</italic> (%)]</td><td align="center" rowspan="1" colspan="1">153 (28.4)</td><td align="center" rowspan="1" colspan="1">138 (29.0)</td><td align="center" rowspan="1" colspan="1">5 (25.0)</td><td align="center" rowspan="1" colspan="1">6 (25.0)</td><td align="center" rowspan="1" colspan="1">58 (28.4)</td><td align="center" rowspan="1" colspan="1">69 (30.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">Stroke history [<italic>n</italic> (%)]</td><td align="center" rowspan="1" colspan="1">33 (6.1)</td><td align="center" rowspan="1" colspan="1">29 (6.1)</td><td align="center" rowspan="1" colspan="1">1 (5.0)</td><td align="center" rowspan="1" colspan="1">1 (4.2)</td><td align="center" rowspan="1" colspan="1">17 (8.3)</td><td align="center" rowspan="1" colspan="1">10 (4.4)</td></tr><tr><td align="left" rowspan="1" colspan="1">Hypertension [<italic>n</italic> (%)]</td><td align="center" rowspan="1" colspan="1">377 (69.9)</td><td align="center" rowspan="1" colspan="1">331 (69.5)</td><td align="center" rowspan="1" colspan="1">14 (70.0)</td><td align="center" rowspan="1" colspan="1">15 (62.5)</td><td align="center" rowspan="1" colspan="1">139 (68.1)</td><td align="center" rowspan="1" colspan="1">163 (71.5)</td></tr><tr><td align="left" rowspan="1" colspan="1">Use of beta-blocker [<italic>n</italic> (%)]</td><td align="center" rowspan="1" colspan="1">181 (33.6)</td><td align="center" rowspan="1" colspan="1">157 (33.0)</td><td align="center" rowspan="1" colspan="1">7 (35.0)</td><td align="center" rowspan="1" colspan="1">5 (20.8)</td><td align="center" rowspan="1" colspan="1">66 (32.4)</td><td align="center" rowspan="1" colspan="1">79 (34.7)</td></tr><tr><td align="left" rowspan="1" colspan="1">Use of Ca channel blocker [<italic>n</italic> (%)]</td><td align="center" rowspan="1" colspan="1">70 (13.0)</td><td align="center" rowspan="1" colspan="1">61 (12.8)</td><td align="center" rowspan="1" colspan="1">1 (5.0)</td><td align="center" rowspan="1" colspan="1">2 (8.3)</td><td align="center" rowspan="1" colspan="1">30 (14.7)</td><td align="center" rowspan="1" colspan="1">28 (12.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">Use of ACE inhibitor [<italic>n</italic> (%)]</td><td align="center" rowspan="1" colspan="1">112 (20.8)</td><td align="center" rowspan="1" colspan="1">105 (22.1)</td><td align="center" rowspan="1" colspan="1">5 (25.0)</td><td align="center" rowspan="1" colspan="1">2 (8.3)</td><td align="center" rowspan="1" colspan="1">37 (18.1)</td><td align="center" rowspan="1" colspan="1">61 (26.8)</td></tr><tr><td colspan="7" align="left" rowspan="1">Heart rate variability<xref ref-type="table-fn" rid="tfn4-ehp0115-001617">c</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Log<sub>10</sub> SDNN (msec)</td><td align="center" rowspan="1" colspan="1">1.52 &#x000b1; 0.25</td><td align="center" rowspan="1" colspan="1">1.52 &#x000b1; 0.25</td><td align="center" rowspan="1" colspan="1">1.53 &#x000b1; 0.24</td><td align="center" rowspan="1" colspan="1">1.48 &#x000b1; 0.21</td><td align="center" rowspan="1" colspan="1">1.52 &#x000b1; 0.26</td><td align="center" rowspan="1" colspan="1">1.53 &#x000b1; 0.25</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Log<sub>10</sub> HF (msec<sup>2</sup>)</td><td align="center" rowspan="1" colspan="1">1.90 &#x000b1; 0.65</td><td align="center" rowspan="1" colspan="1">1.90 &#x000b1; 0.65</td><td align="center" rowspan="1" colspan="1">1.84 &#x000b1; 0.52</td><td align="center" rowspan="1" colspan="1">1.74 &#x000b1; 0.58</td><td align="center" rowspan="1" colspan="1">1.92 &#x000b1; 0.65</td><td align="center" rowspan="1" colspan="1">1.92 &#x000b1; 0.67</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Log<sub>10</sub> LF (msec<sup>2</sup>)</td><td align="center" rowspan="1" colspan="1">2.00 &#x000b1; 0.53</td><td align="center" rowspan="1" colspan="1">2.00 &#x000b1; 0.53</td><td align="center" rowspan="1" colspan="1">1.99 &#x000b1; 0.48</td><td align="center" rowspan="1" colspan="1">1.93 &#x000b1; 0.48</td><td align="center" rowspan="1" colspan="1">2.00 &#x000b1; 0.56</td><td align="center" rowspan="1" colspan="1">2.01 &#x000b1; 0.52</td></tr><tr><td colspan="7" align="left" rowspan="1">Environmental variables</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;PM<sub>2.5</sub><xref ref-type="table-fn" rid="tfn5-ehp0115-001617">d</xref> (&#x003bc;g/m<sup>3</sup>)</td><td align="center" rowspan="1" colspan="1">11.7 &#x000b1; 7.8</td><td align="center" rowspan="1" colspan="1">11.6 &#x000b1; 7.9</td><td align="center" rowspan="1" colspan="1">11.9 &#x000b1; 5.8</td><td align="center" rowspan="1" colspan="1">12.3 &#x000b1; 12.2</td><td align="center" rowspan="1" colspan="1">11.6 &#x000b1; 7.8</td><td align="center" rowspan="1" colspan="1">11.5 &#x000b1; 7.7</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Apparent temperature<xref ref-type="table-fn" rid="tfn5-ehp0115-001617">d</xref> (&#x000b0;C)</td><td align="center" rowspan="1" colspan="1">11.1 &#x000b1; 10.0</td><td align="center" rowspan="1" colspan="1">10.9 &#x000b1; 10.0</td><td align="center" rowspan="1" colspan="1">12.4 &#x000b1; 9.9</td><td align="center" rowspan="1" colspan="1">12.6 &#x000b1; 9.8</td><td align="center" rowspan="1" colspan="1">10.7 &#x000b1; 10.2</td><td align="center" rowspan="1" colspan="1">10.7 &#x000b1; 9.8</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Room temperature (&#x000b0;C)</td><td align="center" rowspan="1" colspan="1">24.3 &#x000b1; 1.8</td><td align="center" rowspan="1" colspan="1">24.3 &#x000b1; 1.8</td><td align="center" rowspan="1" colspan="1">25.0 &#x000b1; 0.9</td><td align="center" rowspan="1" colspan="1">24.8 &#x000b1; 1.8</td><td align="center" rowspan="1" colspan="1">24.3 &#x000b1; 1.7</td><td align="center" rowspan="1" colspan="1">24.2 &#x000b1; 1.9</td></tr></tbody></table><table-wrap-foot><fn id="tfn1-ehp0115-001617"><p>Abbreviations: LDL, low-density lipoprotein.</p></fn><fn id="tfn2-ehp0115-001617"><label>a</label><p>Carriers of &#x0003c; 25 microsatellite (GT) repeats in both alleles.</p></fn><fn id="tfn3-ehp0115-001617"><label>b</label><p>Carriers of &#x02265; 25 microsatellite (GT) repeats in at least one allele.</p></fn><fn id="tfn4-ehp0115-001617"><label>c</label><p>Standard deviation of SDNN, power in HF (0.15&#x02013;0.4 Hz) and LF (0.04&#x02013;0.15 Hz) computed using a fast Fourier transform algorithm.</p></fn><fn id="tfn5-ehp0115-001617"><label>d</label><p>Average of hourly measurements of PM<sub>2.5</sub> and apparent temperature during the 48 hr before the HRV measurement.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t2-ehp0115-001617" position="float"><label>Table 2</label><caption><p>Adjusted percent change (95% CI) of heart rate variability (HRV) for each 10 &#x003bc;g/m<sup>3</sup> of PM<sub>2.5</sub> in the 48 hr before the measurement, by <italic>HMOX-1</italic> micro-satellite repeat length or <italic>GSTM1</italic> polymorphism.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1"/><th colspan="2" align="center" rowspan="1">Model 2 PM<sub>2.5</sub> effect by <italic>GSTM1</italic><hr/></th><th colspan="2" align="center" rowspan="1">Model 3 PM<sub>2.5</sub> effect by <italic>HMOX-1</italic> microsatellite length <hr/></th></tr><tr><th align="left" rowspan="1" colspan="1">HRV measurement<xref ref-type="table-fn" rid="tfn7-ehp0115-001617">a</xref></th><th align="center" rowspan="1" colspan="1">Model 1Main effect of PM<sub>2.5</sub></th><th align="center" rowspan="1" colspan="1"><italic>GSTM1</italic> wild-type</th><th align="center" rowspan="1" colspan="1"><italic>GSTM1</italic> null</th><th align="center" rowspan="1" colspan="1"><italic>HMOX-1</italic> &#x0003c; 25 repeats<xref ref-type="table-fn" rid="tfn8-ehp0115-001617">b</xref></th><th align="center" rowspan="1" colspan="1"><italic>HMOX-1</italic> &#x02265; 25 repeats<xref ref-type="table-fn" rid="tfn9-ehp0115-001617">c</xref></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">log<sub>10</sub> SDNN</td><td align="center" rowspan="1" colspan="1">&#x02212;6.8%</td><td align="center" rowspan="1" colspan="1">&#x02212;2.0%</td><td align="center" rowspan="1" colspan="1">&#x02212;10.5%</td><td align="center" rowspan="1" colspan="1">7.4%</td><td align="center" rowspan="1" colspan="1">&#x02212;8.5%</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">(&#x02212;12.9 to &#x02212;0.2)</td><td align="center" rowspan="1" colspan="1">(&#x02212;11.3 to 8.3)</td><td align="center" rowspan="1" colspan="1">(&#x02212;18.2 to &#x02212;2.2)</td><td align="center" rowspan="1" colspan="1">(&#x02212;8.7 to 26.2)</td><td align="center" rowspan="1" colspan="1">(&#x02212;14.8 to &#x02212;1.8)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><italic>p</italic> = 0.0436</td><td align="center" rowspan="1" colspan="1"><italic>p</italic> = 0.6908</td><td align="center" rowspan="1" colspan="1"><italic>p</italic> = 0.0150</td><td align="center" rowspan="1" colspan="1"><italic>p</italic> = 0.3891</td><td align="center" rowspan="1" colspan="1"><italic>p</italic> = 0.0137</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td colspan="2" align="center" rowspan="1"><italic>p-</italic>interaction = 0.1382</td><td colspan="2" align="center" rowspan="1"><italic>p-</italic>interaction = 0.0594</td></tr><tr><td align="left" rowspan="1" colspan="1">log<sub>10</sub> HF</td><td align="center" rowspan="1" colspan="1">&#x02212;17.3%</td><td align="center" rowspan="1" colspan="1">&#x02212;4.0%</td><td align="center" rowspan="1" colspan="1">&#x02212;24.2%</td><td align="center" rowspan="1" colspan="1">8.9%</td><td align="center" rowspan="1" colspan="1">&#x02212;20.1%</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">(&#x02212;30.0 to &#x02212;2.3)</td><td align="center" rowspan="1" colspan="1">(&#x02212;24.8 to 22.6)</td><td align="center" rowspan="1" colspan="1">(&#x02212;39.2 to &#x02212;5.5)</td><td align="center" rowspan="1" colspan="1">(&#x02212;27.1 to 62.8)</td><td align="center" rowspan="1" colspan="1">(&#x02212;32.9 to &#x02212;5.0)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><italic>p</italic> = 0.0263</td><td align="center" rowspan="1" colspan="1"><italic>p</italic> = 0.7442</td><td align="center" rowspan="1" colspan="1"><italic>p</italic> = 0.0139</td><td align="center" rowspan="1" colspan="1"><italic>p</italic> = 0.6759</td><td align="center" rowspan="1" colspan="1"><italic>p</italic> = 0.0115</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td colspan="2" align="center" rowspan="1"><italic>p-</italic>interaction = 0.1178</td><td colspan="2" align="center" rowspan="1"><italic>p-</italic>interaction = 0.1408</td></tr><tr><td align="left" rowspan="1" colspan="1">log<sub>10</sub> LF</td><td align="center" rowspan="1" colspan="1">&#x02212;11.2%</td><td align="center" rowspan="1" colspan="1">&#x02212;0.6%</td><td align="center" rowspan="1" colspan="1">&#x02212;17.0%</td><td align="center" rowspan="1" colspan="1">14.0%</td><td align="center" rowspan="1" colspan="1">&#x02212;14.0%</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">(&#x02212;22.8 to 2.2)</td><td align="center" rowspan="1" colspan="1">(&#x02212;19.0 to 22.0)</td><td align="center" rowspan="1" colspan="1">(&#x02212;31.0 to &#x02212;0.2)</td><td align="center" rowspan="1" colspan="1">(&#x02212;18.6 to 59.5)</td><td align="center" rowspan="1" colspan="1">(&#x02212;25.7 to &#x02212;0.5)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><italic>p</italic> = 0.0986</td><td align="center" rowspan="1" colspan="1"><italic>p</italic> = 0.9545</td><td align="center" rowspan="1" colspan="1"><italic>p</italic> = 0.0478</td><td align="center" rowspan="1" colspan="1"><italic>p</italic> = 0.4465</td><td align="center" rowspan="1" colspan="1"><italic>p</italic> = 0.0430</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td colspan="2" align="center" rowspan="1"><italic>p-</italic>interaction = 0.1536</td><td colspan="2" align="center" rowspan="1"><italic>p-</italic>interaction = 0.1102</td></tr></tbody></table><table-wrap-foot><fn id="tfn6-ehp0115-001617"><p>All models adjusted for age, BMI, mean arterial pressure, fasting blood glucose, cigarette smoking (never/former/current), alcohol consumption (two or more drinks a day, yes/no), use of beta-blockers, use of calcium channel blockers, use of ACE inhibitor, room temperature, season, and 48-hr moving average of outdoor apparent temperature.</p></fn><fn id="tfn7-ehp0115-001617"><label>a</label><p>Standard deviation of SDNN, power in HF (0.15&#x02013;0.4 Hz) and LF (0.04&#x02013;0.15 Hz) computed using a fast Fourier transform algorithm.</p></fn><fn id="tfn8-ehp0115-001617"><label>b</label><p>Carriers of &#x0003c; 25 microsatellite (GT) repeats in both alleles.</p></fn><fn id="tfn9-ehp0115-001617"><label>c</label><p>Carriers of &#x02265; 25 microsatellite (GT) repeats in at least one allele.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t3-ehp0115-001617" position="float"><label>Table 3</label><caption><p>Effect modification of <italic>HMOX-1</italic> microsatellite repeat length and <italic>GSTM1</italic> combinations on the adjusted percent change (95% CI) of HRV for each 10 &#x003bc;g/m<sup>3</sup> of PM<sub>2.5</sub> in the 48 hr before the measurement.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">HRV measurement<xref ref-type="table-fn" rid="tfn11-ehp0115-001617">a</xref></th><th align="center" rowspan="1" colspan="1"><italic>HMOX-1</italic> &#x0003c; 25 repeats<xref ref-type="table-fn" rid="tfn12-ehp0115-001617">b</xref><italic>GSTM1</italic> wild-type (no. of visits = 26<xref ref-type="table-fn" rid="tfn14-ehp0115-001617">d</xref>)</th><th align="center" rowspan="1" colspan="1"><italic>HMOX-1</italic> &#x0003c; 25 repeats<xref ref-type="table-fn" rid="tfn12-ehp0115-001617">b</xref> and <italic>GSTM1</italic> null or <italic>HMOX-1</italic> &#x02265; 25 repeats<xref ref-type="table-fn" rid="tfn13-ehp0115-001617">c</xref> and <italic>GSTM1</italic> wild-type (no. of visits = 309<xref ref-type="table-fn" rid="tfn14-ehp0115-001617">d</xref>)</th><th align="center" rowspan="1" colspan="1"><italic>HMOX-1</italic> &#x02265; 25 repeats<xref ref-type="table-fn" rid="tfn13-ehp0115-001617">c</xref><italic>GSTM1</italic> null (no. of visits = 303<xref ref-type="table-fn" rid="tfn14-ehp0115-001617">d</xref>)</th><th align="center" rowspan="1" colspan="1">Test for interaction</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Log<sub>10</sub> SDNN</td><td align="center" rowspan="1" colspan="1">28.7% (&#x02212;12.0 to 88.2) <italic>p</italic> = 0.1937</td><td align="center" rowspan="1" colspan="1">&#x02212;2.7% (&#x02212;11.5 to 6.8) <italic>p</italic> = 0.5620</td><td align="center" rowspan="1" colspan="1">&#x02212;12.7% (&#x02212;20.6 to &#x02212;3.9) <italic>p</italic> = 0.0059</td><td align="center" rowspan="1" colspan="1"><italic>p</italic> = 0.0084</td></tr><tr><td align="left" rowspan="1" colspan="1">Log<sub>10</sub> HF</td><td align="center" rowspan="1" colspan="1">45.6% (&#x02212;43.5 to 275.3) <italic>p</italic> = 0.4370</td><td align="center" rowspan="1" colspan="1">&#x02212;5.8% (&#x02212;25.3 to 18.8) <italic>p</italic> = 0.6153</td><td align="center" rowspan="1" colspan="1">&#x02212;27.8% (&#x02212;43.0 to &#x02212;8.5) <italic>p</italic> = 0.0073</td><td align="center" rowspan="1" colspan="1"><italic>p</italic> = 0.0108</td></tr><tr><td align="left" rowspan="1" colspan="1">Log<sub>10</sub> LF</td><td align="center" rowspan="1" colspan="1">68.5% (&#x02212;23.3 to 270.4) <italic>p</italic> = 0.1944</td><td align="center" rowspan="1" colspan="1">&#x02212;2.8% (&#x02212;19.9 to 18.0) <italic>p</italic> = 0.7722</td><td align="center" rowspan="1" colspan="1">&#x02212;20.1% (&#x02212;34.5 to &#x02212;2.7) <italic>p</italic> = 0.0261</td><td align="center" rowspan="1" colspan="1"><italic>p</italic> = 0.0385</td></tr></tbody></table><table-wrap-foot><fn id="tfn10-ehp0115-001617"><p>All models adjusted for age, BMI, mean arterial pressure, fasting blood glucose, cigarette smoking (never/former/current), alcohol consumption (two or more drinks a day, yes/no), use of beta-blockers, use of calcium channel blockers, use of ACE inhibitor, room temperature, season, and 48-hr moving average of outdoor apparent temperature.</p></fn><fn id="tfn11-ehp0115-001617"><label>a</label><p>Standard deviation of SDNN, power in HF (0.15&#x02013;0.4 Hz) and LF (0.04&#x02013;0.15 Hz) computed using a fast Fourier transform algorithm.</p></fn><fn id="tfn12-ehp0115-001617"><label>b</label><p>Carriers of &#x0003c; 25 microsatellite (GT) repeats in both alleles.</p></fn><fn id="tfn13-ehp0115-001617"><label>c</label><p>Carriers of &#x02265; 25 microsatellite (GT) repeats in at least one allele.</p></fn><fn id="tfn14-ehp0115-001617"><label>d</label><p>Number of HRV measurements.</p></fn></table-wrap-foot></table-wrap></floats-wrap></article> 